<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01993589</url>
  </required_header>
  <id_info>
    <org_study_id>{kayseriERH}</org_study_id>
    <nct_id>NCT01993589</nct_id>
  </id_info>
  <brief_title>Effect of Paracetamol, Dexketoprofen Trometamol, Lidocaine Spray, Pethidine and Diclofenac Sodium Application for Pain Relief During Fractional Curettage</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kayseri Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kayseri Education and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients frequently experience pain from moderate to severe during gynecologic procedures.
      This study is a prospective, randomized, placebo-controlled trial and aimed to investigate
      the analgesic efficacy of preoperative oral dexketoprofen trometamol, intravenous
      paracetamol, lidocaine spray, pethidine and diclofenac sodium on fractional curettage
      procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A total of 144 mutiparous subjects randomly allocated one of six groups. The first group
      (control group) consisted of 22 participants and they did not receive any treatment. The
      second group consisted of 26 participants receiving oral 25 mg dexketoprofen trometamol. The
      third group consisted of 23 participants receiving 2 puff lidocaine sprays on cervical
      mucosa. The forth group consisted of 25 participants receiving 100 mg pethidine. The fifth
      group consisted of 23 participants receiving 1000 mg intravenous paracetamol and the sixth
      group consisted of 25 participants receiving diclofenac sodium.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">144</enrollment>
  <condition>Pain and Curettage</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pain reliever</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 mg paracetamol (Parol 1 g Atabay ilaç Turkey)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexketoprofen trometamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 mg oral Dexofen Atabay ilaç Turkey</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine spray</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 puff on cervical mucosa (Xylocain Pump 100 Mg 50 Ml Sprey Astra Zeneca)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pethidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Aldolan 100 mg Liba Laboratuarı İstanbul Turkey</description>
  </arm_group>
  <arm_group>
    <arm_group_label>diclofenac sodium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dicloron amp 75 mg Deva İlaç Levent İstanbul/Turkey</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of pain relievers during curattage</intervention_name>
    <arm_group_label>Pain reliever</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of pain relievers</intervention_name>
    <arm_group_label>Dexketoprofen trometamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of pain relievers during curattage</intervention_name>
    <arm_group_label>Lidocaine spray</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of pain relievers during curattage</intervention_name>
    <arm_group_label>pethidine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>comparison of pain relievers during curattage</intervention_name>
    <arm_group_label>diclofenac sodium</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  multiparous participants

          -  abnormal uterine bleeding

          -  postmenopausal bleeding

          -  myoma uteri causing menometrorrhagia

          -  cervical polyp

          -  tamoxifen treatment for breast cancer

          -  adnexial mass

        Exclusion Criteria:

          -  abortions

          -  pregnancy

          -  primiparity

          -  diabetes mellitus

          -  tendency to bleed such as thrombocytopenia

          -  factor deficiency

          -  functional disorders of platelets
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Kayseri Education and Research Hospital of Medicine</name>
      <address>
        <city>Kayseri</city>
        <zip>38210</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2013</study_first_submitted>
  <study_first_submitted_qc>November 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>November 20, 2013</last_update_submitted>
  <last_update_submitted_qc>November 20, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kayseri Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Gökhan Açmaz</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Curettage; analgesia; paracetamol; lidocaine; Dexketoprofen trometamol; pethidine; diclofenac.</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Meperidine</mesh_term>
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

